The Journal of Allergy and Clinical Immunology
Volume 116, Issue 6 , Pages 1213-1219, December 2005

Irreversible lung function deficits in young adults with a history of childhood asthma

  • Susan L. Limb, MD

      Affiliations

    • From the Division of Allergy and Clinical Immunology
  • ,
  • Kathryn C. Brown, MD

      Affiliations

    • From the Division of Allergy and Clinical Immunology
  • ,
  • Robert A. Wood, MD

      Affiliations

    • Department of Pediatrics
  • ,
  • Robert A. Wise, MD

      Affiliations

    • Divisions of Pulmonology and Critical Care Medicine, Johns Hopkins School of Medicine
  • ,
  • Peyton A. Eggleston, MD

      Affiliations

    • Department of Pediatrics
  • ,
  • James Tonascia, PhD

      Affiliations

    • Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University
  • ,
  • N. Franklin Adkinson Jr., MD

      Affiliations

    • From the Division of Allergy and Clinical Immunology
    • Corresponding Author InformationReprint requests: N. Franklin Adkinson, Jr, MD, JHAAC Rm 2A.62, 5501 Hopkins Bayview Circle, Baltimore, MD 21224.

Received 8 August 2005; received in revised form 13 September 2005; accepted 19 September 2005. published online 08 November 2005.

Baltimore, Md

Background

Asthma, traditionally characterized as reversible airway obstruction, might lead to structural changes and permanent impairment.

Objective

We sought to study the frequency, severity, and reversibility of pulmonary deficits in adults with a history of moderate-to-severe childhood allergic asthma.

Methods

Subjects (n = 121) previously enrolled in a randomized trial of immunotherapy for childhood asthma were recalled. Eighty-four young adults (age, 17-30 years; 78% male) were reevaluated by means of spirometry. Subjects with a postbronchodilator FEV1, forced vital capacity, or FEV1/forced vital capacity ratio less than or equal to the 5th percentile or 2 or more indices less than or equal to the 10th percentile (National Health and Nutrition Examination Survey III normative data) were invited to undergo complete pulmonary function testing, physical examination, and chest radiography after 1 week of 1 mg/kg daily prednisone.

Results

Of 84 subjects reevaluated, 40 (48%) had one or more spirometric indices less than or equal to the 5th and 10th percentiles (P < .0001). Twenty-eight of the 40 subjects were reassessed after prednisone treatment, of whom 21 (75%) did not improve. Adult and childhood (age 5-12 years) spirometric results were positively correlated (r = 0.49-0.72, P < .001). Abnormal adult spirometric results were associated with a longer duration of asthma at enrollment in the original trial (4.6 vs 6 years, P = .02), increased childhood methacholine sensitivity (PC20, 0.11 vs 0.18 mg/mL; P = .01), and birth prematurity (adjusted odds ratio, 10.7; 95% CI, 1.4-84.5). Immunotherapy status was unrelated to adult lung function.

Conclusions

Many adults with a history of moderate-to-severe allergic asthma in childhood have irreversible lung function deficits. Childhood spirometry, duration of asthma, methacholine sensitivity, and birth prematurity might identify such individuals at a young age.

Key words: Childhood asthma, pulmonary function test, spirometry, methacholine sensitivity

Abbreviations used: CAMP, Childhood Asthma Management Program, CAS, Childhood Asthma Study, FVC, Forced vital capacity, OR, Odds ratio

 

 Supported by the Philip Morris External Research Program and National Institutes of Health, National Center for Research Resources, grant no. 5M01RR02719 to The Johns Hopkins Bayview General Clinical Research Center.

PII: S0091-6749(05)02110-X

doi:10.1016/j.jaci.2005.09.024

The Journal of Allergy and Clinical Immunology
Volume 116, Issue 6 , Pages 1213-1219, December 2005